Prevention

Photo

News • DNA analysis

Should all babies have their genome sequenced at birth?

Genomics England, a government owned company, recently announced a pilot programme of whole genome sequencing to screen for genetic diseases in 200,000 healthy seeming newborns. But should every newborn baby have their whole genome sequenced? Experts debate the issue in The BMJ. Extensive clinical evidence has shown that screening for genetic diseases saves lives, and research has shown that it…

Photo

Sponsored • Listen to the experts

Patient Safety in Endoscopy – The Podcast

Increasing collaboration between health care providers and the medical industry is proven to be beneficial as it continues to pave the way for innovative technologies. By bringing expert opinions to the table, we can explore patient safety and infection prevention, discussing what can further be done to improve the endoscopic field. Sparked your interest?

Photo

News • Blindness prevention

Blue is the clue for diabetic retinopathy risk

Researchers from Tokyo Medical and Dental University (TMDU) demonstrate a thorough and non-invasive imaging technique to identify areas of the eye affected by diabetic retinopathy (DR), a progressive eye disease associated with diabetes and a leading cause of blindness. The researchers have found that blue light can be used to probe the depths of the eye and uncover areas affected by DR.

Photo

News • Addressing coronavirus vaccine hesitancy

Covid-19: Could a chatbot help overcome vaccine concerns?

French researchers have found that addressing concerns related to the Covid-19 vaccination via a chatbot interface might be capable of swaying the vaccine-hesitant. Vaccine hesitancy is one of the major challenges in containing the Covid-19 pandemic. Previous studies have revealed that mass communication—through short messages relayed by television or radio—is not a very effective means of…

Photo

Video • Prevention of triple-negative BRCA

Breast cancer vaccine: clinical trial started

Researchers from Cleveland Clinic have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. This phase I trial is designed to determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer and to characterize and optimize the body’s immune response. The…

567 show more articles
Subscribe to Newsletter